|
|
Article: Financings Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- February 13, 2009
- Author:
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Alios Closes $8.4M Tranche of $24M Series A Round, , From Staff Reports
Alios BioPharma Inc. concluded the first closing of a Series A preferred stock financing with a commitment from new investors of $24 million to build its antiviral therapy programs.
The first tranche of $8.4 million has been completed, led by Novo Ventures and Novartis Ventures with participation from the Roche Venture Fund. Jack B. Nielsen from Novo Ventures will serve as board chairman. Also joining the board is Campbell Murray from Novartis Ventures, and Carole Nuechterlein from Roche Venture Fund will sit as an observer.
Alios, of South San Francisco, was founded ...